teclistamab,daratumumab,talquetamab
genmab,janssen
['talquetamab', 'mmsm', 'teclistamab']
is it time to redirectt myeloma? combining teclistamab and talquetamab is feasible but crs and infections still common as with monotherapies. efficacy is very impressive with orr over 90%!! #asco23 #mmsm #mediq23asco 
We empower people at every level of the healthcare delivery system with the knowledge needed to continuously improve provider performance and patient outcomes.